Evidence mapPaperPMID 37702736Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2023

Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods.

Benedikt A Aulinger, David A D'Alessio

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Benedikt A AulingerDepartment of Medicine II, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-8292-7456
David A D'AlessioDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Duke University, Durham, North Carolina, United States.ORCID 0000-0003-4155-4870
Duke University · USLMU Klinikum · DE

Funding

NCATS NIH HHS UL1 TR000077
6 · The paper itself

Abstract

The incretin effect describes the insulin response to nutrient ingestion that exceeds the response to glycemia per se. It is mediated by gastrointestinal factors and is necessary to maintain postprandial glucose homeostasis. The incretin effect results in a more than twofold increase of the insulin response to a meal in healthy people and two different techniques have been used in the past to measure its magnitude. Most studies employ an OGTT on 1 day, followed by a matching glucose infusion on a separate day. Another study design employs a hyperglycemic glucose clamp that is maintained after oral ingestion of glucose. Both protocols allow quantification of the incretin effect by comparing the insulin response to an identical glycemic stimulus. Here we performed a within-subject comparison of both techniques to quantify the incretin effect and suggest different calculation methods to interpret the results derived from the clamp experiment in a cohort of healthy young adults (

Indexed as

Blood GlucoseIncretinsAdultC-PeptideGastric Inhibitory PolypeptideGlucagon-Like Peptide 1GlucoseGlucose Tolerance TestHealthy VolunteersHumansInsulinYoung AdultBlood GlucoseC-PeptideGastric Inhibitory PolypeptideGlucagon-Like Peptide 1GlucoseIncretinsInsulinGIPGLP-1glucose toleranceincretin effectinsulin secretion

Identifiers

PMID37702736
PMCPMC10642988
OpenAlexW4386704634

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.